Racial minorities and people with lower incomes or who are insured by Medicare or Medicaid are significantly less likely to receive the most advanced therapies and more likely to die after suffering a pulmonary embolism, according to a new analysis conducted by University of Vermont Professor of Medicine Mary Cushman, M.D., M.Sc., and colleagues.

(DECEMBER 10, 2022) Trial investigator Mary Cushman, M.D., professor of medicine, presented study findings on social determinants of health [SDOH] and pulmonary embolism treatment and mortality at the American Society of Hematology Annual Meeting, Pharmacy Times reported.

These awards, supported wholly by funds from UVM entities, provide $200,000 over 2 years to fund meritorious research from early career faculty. We are very grateful to Deans from the Colleges of Medicine, Nursing & Health Sciences, Arts & Sciences, Engineering & Mathematical Sciences, and the Graduate College, as well as the Cardiovascular Research Institute of Vermont, for their support of this program. In addition, we would like to acknowledge matching fund support from the Departments of Molecular Physiology and Biophysics and Medicine.

(DECEMBER 2, 2022) Research by Professor of Medicine Neil A. Zakai, M.D., and colleagues shows that increased coronary heart disease risk in White but not Black adults is associated with lower levels of high-density lipoprotein cholesterol, according to HealthDay News.